Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
O n Tuesday, researchers at Stanford and Yale revealed something that AI companies would prefer to keep hidden. Four popular ...
DeepSeek has expanded its R1 whitepaper by 60 pages to disclose training secrets, clearing the path for a rumored V4 coding ...